Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Gritstone bio, Inc. | grts-ex321_7.htm |
| EX-31.2 - EX-31.2 - Gritstone bio, Inc. | grts-ex312_10.htm |
| EX-31.1 - EX-31.1 - Gritstone bio, Inc. | grts-ex311_8.htm |
| 10-K - 10-K - Gritstone bio, Inc. | grts-10k_20201231.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
|
|
(1) |
Registration Statements (Form S-3 Nos. 333-234211 and 333-252564) and related Prospectuses of Gritstone Oncology, Inc., |
|
|
(2) |
Registration Statements (Form S-8 Nos. 333-230581 and 333-237095) pertaining to the 2018 Incentive Award Plan and 2018 Employee Stock Purchase Plan of Gritstone Oncology, Inc., and |
|
|
(3) |
Registration Statement (Form S-8 No. 333-227665) pertaining to the 2015 Equity Incentive Plan, the 2018 Incentive Award Plan, and 2018 Employee Stock Purchase Plan of Gritstone Oncology, Inc. |
of our report dated March 11, 2021, with respect to the consolidated financial statements of Gritstone Oncology, Inc. included in this Annual Report (Form 10-K) of Gritstone Oncology, Inc. for the year ended December 31, 2020.
/s/ Ernst & Young LLP
Redwood City, California
March 11, 2021